Global Digital Pathology Market By Technology (Whole Slide Imaging, Telepathology, Static, Dynamic), By Application (Disease Diagnosis, Academics, Drug Discovery & Development) Is Expected To Reach USD 692.5 Million By 2022 - Grand View Research, Inc.
Global digital pathology market is expected to reach USD 692.5 million by 2022, according to a new study by Grand View Research, Inc. Increasing automation in the field of in vitro diagnostics especially pertaining to pathology is expected to drive the growth of the digital pathology market over the forecast period. Growing prevalence of chronic diseases such as cancer is further expected to heighten the demand for faster and accurate diagnostic tools. Growth in the penetration rates of EHR in the North American and European regions is also likely to have a positive impact on market growth over the forecast period. Inherent advantages associated with digital pathology systems are expected to boost usage rates. Consumers are expected to initiate the use of digital pathology systems in an attempt to curb costs, render improved patient care, improve workflow system and minimize human error related incidences. Whole slide imaging is expected to grow at a lucrative rate. The technology renders high resolution digital images with multiple magnifications in a shorter period of time and this is expected to promote usage rates over the forecast period. View summary of this report @ analysis/digital-pathology-systems-market
http://www.grandviewresearch.com/industry-
Global digital pathology market, by region, 2012 – 2022 (USD Million)
Table of Content Chapter 1. Executive Summary 1.1. Digital Pathology Market - Industry Summary and Critical Success Factors (CSFs) Chapter 2. Digital Pathology Industry Outlook 2.1. Digital Pathology Market Segmentation 2.2. Digital Pathology Market Size and Growth Prospects 2.3. Digital Pathology Market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Digital Pathology Company Market Share, 2014 2.7. Digital Pathology Market PESTEL Analysis, 2014 Chapter 3. Digital Pathology Technology Outlook 3.1. Digital Pathology Market Share By Technology, 2014 & 2022
3.2. Whole Slide Imaging 3.2.1. Whole Slide Imaging Market Estimates and Forecasts, 2012 – 2022 (USD Million) 3.3. Telepathology 3.3.1. Telepathology Market Estimates and Forecasts, 2012 – 2022 (USD Million) 3.3.1.1. Static Telepathology Market Estimates and Forecasts, 2012 – 2022 (USD Million) 3.3.1.2. Dynamic Telepathology Market Estimates and Forecasts, 2012 – 2022 (USD Million) Chapter 4. Digital Pathology Application Outlook 4.1. Digital Pathology Market Share By Application, 2014 & 2022 4.2. Disease Diagnosis 4.2.1. Disease Diagnosis Market Estimates and Forecasts, 2012 – 2022 (USD Million) 4.3. Academics 4.3.1. Academics Market Estimates and Forecasts, 2012 – 2022 (USD Million) 4.4. Drug Discovery and Development 4.4.1. Drug Discovery & Development Market Estimates and Forecasts, 2012 – 2022 (USD Million) Chapter 5. Digital Pathology Regional Outlook 5.1. Digital Pathology Market Share By Region, 2014 & 2022 5.2. North America 5.2.1. North America Digital Pathology Market Estimates and Forecasts, 2012 – 2022 (USD Million) 5.2.2. U.S. Market Estimates and Forecasts 5.2.3. Canada Market Estimates and Forecasts 5.3. Europe 5.3.1. Europe Digital Pathology Market Estimates and Forecasts, 2012 – 2022 (USD Million) 5.3.2. Germany Market Estimates and Forecasts 5.3.3. UK Market Estimates and Forecasts 5.4. Asia Pacific 5.4.1. Asia Pacific Digital Pathology Market Estimates and Forecasts, 2012 – 2022 (USD Million) 5.4.2. Japan Market Estimates and Forecasts 5.4.3. China Market Estimates and Forecasts 5.5. Latin America
5.5.1. Latin America Digital Pathology Market Estimates and Forecasts, 2012 – 2022 (USD Million) 5.5.2. Mexico Market Estimates and Forecast 5.5.3. Brazil Market Estimates and Forecast 5.6. Middle East and Africa (MEA) 5.6.1. MEA Digital Pathology Market Estimates and Forecasts, 2012 – 2022 (USD Million) 5.6.2. South Africa Market Estimates and Forecast Chapter 6. Competitive Landscape 6.1. Leica Biosystems 6.1.1. Company Overview 6.1.2. Financial Performance 6.1.3. Product Benchmarking 6.1.4. Strategic Initiatives 6.2. Hamamatsu Photonics Inc. 6.2.1. Company Overview 6.2.2. Financial Performance 6.2.3. Product Benchmarking 6.2.4. Strategic Initiatives 6.3. Philips Healthcare 6.3.1. Company Overview 6.3.2. Financial Performance 6.3.3. Product Benchmarking 6.3.4. Strategic Initiatives 6.4. Olympus Corporation 6.4.1. Company Overview 6.4.2. Financial Performance 6.4.3. Product Benchmarking 6.4.4. Strategic Initiatives 6.5. Ventana Medical Systems, Inc. 6.5.1. Company Overview 6.5.2. Financial Performance 6.5.3. Product Benchmarking 6.5.4. Strategic Initiatives 6.6. GE Healthcare 6.6.1. Company Overview 6.6.2. Financial Performance 6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives 6.7. Microskan technologies 6.7.1. Company Overview 6.7.2. Financial Performance 6.7.3. Product Benchmarking 6.7.4. Strategic Initiatives 6.8. Omynx LLC. 6.8.1. Company Overview 6.8.2. Financial Performance 6.8.3. Product Benchmarking 6.8.4. Strategic Initiatives 6.9. Definiens 6.9.1. Company Overview 6.9.2. Financial Performance 6.9.3. Product Benchmarking 6.9.4. Strategic Initiatives 6.10. Indica Labs Inc. 6.10.1. Company Overview 6.10.2. Financial Performance 6.10.3. Product Benchmarking 6.10.4. Strategic Initiatives 6.11. Digipath Inc. 6.11.1. Company Overview 6.11.2. Financial Performance 6.11.3. Product Benchmarking 6.11.4. Strategic Initiatives 6.12. 3DHISTECH Ltd. 6.12.1. Company Overview 6.12.2. Financial Performance 6.12.3. Product Benchmarking 6.12.4. Strategic Initiatives 6.13. Objective Pathology 6.13.1. Company Overview 6.13.2. Financial Performance 6.13.3. Product Benchmarking 6.13.4. Strategic Initiatives 6.14. Nikon Instruments 6.14.1. Company Overview
6.14.2. Financial Performance 6.14.3. Product Benchmarking 6.14.4. Strategic Initiatives 6.15. LigoLab LLC 6.15.1. Company Overview 6.15.2. Financial Performance 6.15.3. Product Benchmarking 6.15.4. Strategic Initiatives 6.16. Apollo Pacs, Inc. 6.16.1. Company Overview 6.16.2. Financial Performance 6.16.3. Product Benchmarking 6.17. PathXL 6.17.1. Company Overview 6.17.2. Financial Performance 6.17.3. Product Benchmarking 6.17.4. Strategic Initiatives
Browse full report @ pathology-systems-market
http://www.grandviewresearch.com/industry-analysis/digital-
List of Tables 1. Digital Pathology– Industry summary &Critical Success Factors (CSFs) 2. Digital Pathology Market by Product, (USD million), 2012 - 2022 3. Digital Pathology Market – Key market drivers analysis 4. Digital Pathology Market – Key market restraints analysis 5. Whole slide Imaging Market, 2012 to 2022 (USD million) 6. Telepathology Market, 2012 to 2022 (USD million) 7. Static Telepathology Market, 2012 to 2022 (USD million) 8. Dynamic Telepathology Market, 2012 to 2022 (USD million) 9. Disease Diagnosis Market, 2012 to 2022 (USD million) 10. Academics Market, 2012 to 2022 (USD million) 11. Drug Discovery & Development Market, 2012 to 2022 (USD million) 12. Digital Pathology Market Revenue By Manufacturers,(USD million),2012 – 2022 13. Global Digital Pathology Market, By Region, 2012 to 2022 (USD million) 14. North America Digital Pathology Demand, By Technology, (USD million), 2012 – 2022
15. Europe Digital Pathology Demand, By Technology, (USD million), 2012 – 2022 16. Asia Pacific Digital Pathology Demand, By Technology, (USD million), 2012 – 2022 17. Latin America Digital Pathology Demand, By Technology, (USD million), 2012 – 2022 18. MEA Digital Pathology Demand, By Technology, (USD million), 2012 – 2022 For More Information visit http://www.grandviewresearch.com/industry-analysis/digitalpathology-systems-market
List of Figures 1. Digital Pathology Market Segmentation 2. Global Digital Pathology Market Revenue, 2012 - 2022 3. Digital Pathology Market Dynamics 4. Digital Pathology Company Market Share Analysis, 2012 5. Key Opportunities Prioritized 6. Industry Analysis - Porter's 7. Digital Pathology PESTEL Analysis, 2012 8. Global Digital Pathology Market , By Technology, (USD million), 2012 – 2022 9. Global Digital Pathology Market, By Region 2012 to 2022 (USD million) 10. Whole Slide Imaging Market, By Region, (USD million), 2012 – 2022 11. Static Telepathology Market, By Region, (USD million), 2012 – 2022 12. Dynamic Telepathology Market, By Region, (USD million), 2012 – 2022 13. Disease Diagnosis Market, by region 2012 to 2022 (USD million) 14. Academics Market, by region 2012 to 2022 (USD million) 15. Drug Discovery and Development Market, by region 2012 to 2022 (USD million) 16. Digital Pathologys market - Company market share analysis, 2013 (%)
Further key findings from the study suggest:
Digital pathology services found the largest application in disease diagnosis in 2014. Increasing prevalence of cancer & other chronic diseases heightening the demand for accurate and faster diagnostic tools and greater applicability are some factors accounting for its large share. North America was the most matured regional digital pathology market in 2014 and accounted for over 40.0% of revenue. Presence of sophisticated healthcare infrastructure favoring the implementation of electronic medical records and growing demand for device automation is some factors responsible for its large share. Asia Pacific region on account of the presence of large untapped opportunities, rapidly improving healthcare infrastructure and increasing usage of digital pathology in academics and research is expected to provide this market with lucrative future growth opportunities.
Some key players of digital pathology services include GE Healthcare, 3DHistech Inc., Leica Biosystems, Ventana Medical Systems, Inc., Philips Healthcare, Definiens, Olympus Corporation, Omynx LLC, Objective Pathology Services, LigoLAb LLC, Hamamatsu Photonics Inc., and MicroSkan Technologies. Providing technologically advanced pathological systems & services and capitalizing on the untapped opportunities via strategic collaborations are some key strategic moves adopted by these market players.
Request free sample of this Report @ http://www.grandviewresearch.com/industryanalysis/digital-pathology-systems-market/request For the purpose of this study, Grand View Research has segmented the global digital pathology market on the basis of technology, application and region: Global Digital Pathology Technology Outlook (Revenue, USD Million, 2012 – 2022)
Whole slide Imaging Telepathology Static Dynamic
Global Digital Pathology Application Outlook (Revenue, USD Million, 2012 – 2022)
Drug Discovery & Development Academic Disease Diagnosis
Digital Pathology Regional Outlook (Revenue, USD Billion, 2012 – 2022)
North America U.S. Canada Europe UK Germany Asia Pacific China Japan Latin America Brazil Mexico MEA

Browse
South Afric All
Reports
of
this
category
@
http://www.grandviewresearch.com/industry/medical-devices
About Grand View Research Grand View Research, Inc. is a market research and consulting company that provides off-theshelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deepseated understanding of varied business environments, Grand View Research provides strategic objective insights.
Contact: Sherry James Corporate Sales Specialist, U.S.A. Grand View Research, Inc. United States Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Website: Grand View Research Blog Site: http://www.divog.org/